Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity.
about
Modeling Barrier Tissues In Vitro: Methods, Achievements, and ChallengesBiomedical microelectromechanical systems (BioMEMS): Revolution in drug delivery and analytical techniquesMicrofluidic Organ/Body-on-a-Chip Devices at the Convergence of Biology and Microengineering.Microfabricated mammalian organ systems and their integration into models of whole animals and humansTEER measurement techniques for in vitro barrier model systemsProtein expression profiles of intestinal epithelial co-cultures: effect of functionalised carbon nanotube exposureBiology-inspired microphysiological system approaches to solve the prediction dilemma of substance testingAccelerating drug discovery via organs-on-chips.Advances in microfluidic materials, functions, integration, and applications.Engineering hydrogels as extracellular matrix mimicsMicrophysiological systems and low-cost microfluidic platform with analytics.How multi-organ microdevices can help foster drug developmentBody-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injuryDevelopment of disposable PDMS micro cell culture analog devices with photopolymerizable hydrogel encapsulating living cells.Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems.Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposureHuman-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling.Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow.Biomimetic tissues on a chip for drug discovery.Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.Progress and future of in vitro models to study translocation of nanoparticles.Microfabrication technologies for oral drug delivery.Microfluidics meets metabolomics to reveal the impact of Campylobacter jejuni infection on biochemical pathways.The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?Proteomic profiling of halloysite clay nanotube exposure in intestinal cell co-cultureIntegration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling.Microfluidic devices for in vitro studies on liver drug metabolism and toxicity.The current status of alternatives to animal testing and predictive toxicology methods using liver microfluidic biochips.Microtechnology for mimicking in vivo tissue environment.Modeling life.Advances in microfluidics for drug discovery.Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening.Droplet-based microfluidics: enabling impact on drug discovery.Organs-on-a-chip: a new tool for drug discovery.In vitro micro-physiological models for translational immunology.3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip.A Review of the Application of Body-on-a-Chip for Drug Test and Its Latest Trend of Incorporating Barrier Tissue.From Microscale Devices to 3D Printing: Advances in Fabrication of 3D Cardiovascular Tissues.Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions.Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery.
P2860
Q26748486-3471658A-36F1-48EF-AFA6-467622B7D17BQ26768245-B975E735-58DF-4CF9-90D6-7F4FCE44FB59Q26774240-8496DAC1-AAB2-4648-AD4B-CD1700F49FA0Q27011459-CB6A9125-8428-4D6C-87A3-228E0AFC1B9EQ28086851-658DED6A-7335-404E-B609-32FCF5DB9391Q28390771-03966B28-91C5-4ECA-9B8B-68234593C6ACQ30358385-037B173C-874F-440D-9C96-D59563D0B53DQ30422679-29218BF8-340A-42F6-9300-96CB0C34814FQ30440267-B6FC28C2-978F-43CF-94A1-6C5370C68532Q30477371-2BB62CA9-E086-4AA0-A721-F079A6E7FDC2Q33645219-1DC9DE9C-9DCA-44AF-B0A7-D8466925D704Q33893475-23439191-04F5-4B7A-ACDF-8881A8EBE67FQ34088840-E32EA0D0-7DCD-4EDD-8ED4-9B321939280DQ34097011-A8C335DC-2A20-4689-AC08-C66B10BFD949Q34143148-AED62912-7C40-4FD7-BE4C-278D7E5A196EQ34143269-188E7401-46E9-4272-82E4-7260865ADA80Q35532165-AA7A9EAD-6594-4365-AF20-535A9C50187DQ35577829-14C9A9D1-CCA4-47C6-BC80-751CE608723EQ35739950-D23EB186-73CF-40D1-A0AB-52A21A3BDB6DQ35826421-81EA5125-2151-4942-BFC9-105F22562613Q36001471-1B200059-44AF-4714-A55E-1A30D3E69F67Q36501907-6A98B68A-4191-479A-842E-4ABCF689B2FBQ37082323-8AEEADAF-4C47-44CD-A7B3-A926F75EF894Q37174716-3BEB7D07-C5E1-4458-91B5-59CA91FB942AQ37213510-31E762F8-518E-4BB1-90C9-2A100BBB8952Q37764345-F07C2DCD-C841-4BF0-A0D7-8C0A618E32C4Q37844444-E410D263-4AFC-49DE-B2C0-6E7273945E0FQ37967417-7EE4F8C0-6E32-4F89-AB19-0353E1C9A4FDQ37973002-3664C41A-3661-4B97-8416-D5C49AAE8083Q38004843-2B7079BB-56E3-4E7D-94B0-C631E8236ADCQ38029121-5CBEDBF5-8077-491C-96B1-7658B182E0B7Q38137976-2F6FD2F3-897B-4E5B-9B9F-31512737C52CQ38163391-27DFE242-7E59-4AA1-A4A9-4141228EAFE0Q38195304-96A0DE4D-0ADB-45D3-BD97-3DA6254CD16FQ38287065-81E94ECC-F5AC-4EBF-980A-C69DB0C33A5DQ38567885-16CC91CE-3431-4714-B25C-EB76E7C86FD1Q38684521-C8FC0751-4366-44F9-ABB8-036348F6C720Q38774307-B0A315FD-1E55-4DC1-A808-21D4A4D10A77Q38799238-0D880B60-91F7-4A92-8408-4FE8EE994EF0Q38816248-2DBC07BF-6551-4FD1-86E6-60A75C3EC119
P2860
Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Characterization of a gastroin ...... used to predict drug toxicity.
@en
Characterization of a gastroin ...... used to predict drug toxicity.
@nl
type
label
Characterization of a gastroin ...... used to predict drug toxicity.
@en
Characterization of a gastroin ...... used to predict drug toxicity.
@nl
prefLabel
Characterization of a gastroin ...... used to predict drug toxicity.
@en
Characterization of a gastroin ...... used to predict drug toxicity.
@nl
P2093
P356
P1476
Characterization of a gastroin ...... used to predict drug toxicity.
@en
P2093
Gretchen J Mahler
Mandy B Esch
Michael L Shuler
Raymond P Glahn
P304
P356
10.1002/BIT.22366
P577
2009-09-01T00:00:00Z